{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:52:29Z","timestamp":1778802749952,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejoncologynursing.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Oncology Nursing"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ejon.2023.102355","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T15:46:13Z","timestamp":1686152773000},"page":"102355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Incidence and predictors of abdominal pain after transarterial chemoembolization of hepatocellular carcinoma: a single-center retrospective study"],"prefix":"10.1016","volume":"66","author":[{"given":"Qian-qian","family":"Du","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-ling","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9585-3230","authenticated-orcid":false,"given":"Jia-hu","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejon.2023.102355_bib1","first-page":"241","article-title":"Identifying predictors and evaluating the role of steroids in the prevention of post-embolization syndrome after transarterial chemoembolization and bland embolization","volume":"34","author":"Agrawal","year":"2021","journal-title":"Ann. Gastroenterol."},{"issue":"4","key":"10.1016\/j.ejon.2023.102355_bib2","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/liv.13235","article-title":"Risks factors for severe pain after selective liver transarterial chemoembolization","volume":"37","author":"Benzakoun","year":"2017","journal-title":"Liver Int."},{"issue":"30","key":"10.1016\/j.ejon.2023.102355_bib3","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.3748\/wjg.v26.i30.4442","article-title":"Predictive model for acute abdominal pain after transarterial chemoembolization for liver cancer","volume":"26","author":"Bian","year":"2020","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.ejon.2023.102355_bib4","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1097\/NCC.0000000000000302","article-title":"Management of postembolization syndrome following hepatic transarterial chemoembolization for primary or metastatic liver cancer","volume":"39","author":"Blackburn","year":"2016","journal-title":"Cancer Nurs."},{"issue":"2","key":"10.1016\/j.ejon.2023.102355_bib5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4103\/2347-5625.204497","article-title":"Hepatocellular carcinoma: implications for Asia-Pacific oncology nurses","volume":"4","author":"Boyle","year":"2017","journal-title":"Asia Pac J Oncol Nurs"},{"issue":"20","key":"10.1016\/j.ejon.2023.102355_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13205129","article-title":"In the era of systemic therapy for hepatocellular carcinoma is transarterial chemoembolization still a card to play?","volume":"13","author":"Bucalau","year":"2021","journal-title":"Cancers"},{"issue":"24","key":"10.1016\/j.ejon.2023.102355_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13246172","article-title":"Conventional transarterial chemoembolization versus Drug-Eluting beads in patients with hepatocellular carcinoma: a systematic review and Meta-Analysis","volume":"13","author":"Bzeizi","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ejon.2023.102355_bib8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/s12876-022-02529-x","article-title":"The impact of symptom distress on health-related quality of life in liver cancer patients receiving arterial chemoembolization: the mediating role of hope","volume":"22","author":"Chen","year":"2022","journal-title":"BMC Gastroenterol."},{"issue":"3","key":"10.1016\/j.ejon.2023.102355_bib9","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00270-015-1208-y","article-title":"Treatment of liver tumors with lipiodol TACE: technical recommendations from experts opinion","volume":"39","author":"de Baere","year":"2016","journal-title":"Cardiovasc. Intervent. Radiol."},{"issue":"2","key":"10.1016\/j.ejon.2023.102355_bib10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1055\/s-0031-1280666","article-title":"Hepatic transcatheter arterial chemoembolization complicated by postembolization syndrome","volume":"28","author":"Dhand","year":"2011","journal-title":"Semin. Intervent. Radiol."},{"issue":"2","key":"10.1016\/j.ejon.2023.102355_bib11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3748\/wjg.v24.i2.161","article-title":"Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: current state of the art","volume":"24","author":"Facciorusso","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"18","key":"10.1016\/j.ejon.2023.102355_bib12","first-page":"2824","article-title":"The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review","volume":"120","author":"Fong","year":"2014","journal-title":"Cancer-Am. Cancer Soc."},{"issue":"9","key":"10.1016\/j.ejon.2023.102355_bib13","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jvir.2017.04.025","article-title":"Quality improvement guidelines for transarterial chemoembolization and embolization of hepatic malignancy","volume":"28","author":"Gaba","year":"2017","journal-title":"J. Vasc. Intervent. Radiol."},{"issue":"1","key":"10.1016\/j.ejon.2023.102355_bib14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","author":"Galle","year":"2018","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.ejon.2023.102355_bib15","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1007\/s00432-018-2704-7","article-title":"Quality of life in patients undergoing repetitive TACE for the treatment of intermediate stage HCC","volume":"144","author":"Hartrumpf","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ejon.2023.102355_bib16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.4103\/jcrt.jcrt_132_21","article-title":"Factors influencing postembolization syndrome in patients with hepatocellular carcinoma undergoing first transcatheter arterial chemoembolization","volume":"17","author":"He","year":"2021","journal-title":"J. Cancer Res. Therapeut."},{"issue":"10","key":"10.1016\/j.ejon.2023.102355_bib17","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s00270-017-1681-6","article-title":"Health-Related quality of life in patients with hepatocellular carcinoma treated with initial transarterial chemoembolization","volume":"40","author":"Hinrichs","year":"2017","journal-title":"Cardiovasc. Intervent. Radiol."},{"issue":"4","key":"10.1016\/j.ejon.2023.102355_bib18","doi-asserted-by":"crossref","first-page":"764","DOI":"10.2214\/AJR.15.14825","article-title":"Development of conventional transarterial chemoembolization for hepatocellular carcinomas in Japan: historical, strategic, and technical review","volume":"205","author":"Horikawa","year":"2015","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ejon.2023.102355_bib19","article-title":"Cancer statistics in Chinese older people, 2022: current burden, time trends, and comparisons with the US, Japan, and the Republic of Korea","author":"Ju","year":"2022","journal-title":"Sci. China Life Sci."},{"issue":"1","key":"10.1016\/j.ejon.2023.102355_bib20","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1148\/radiol.2018180257","article-title":"A predictive model for postembolization syndrome after transarterial hepatic chemoembolization of hepatocellular carcinoma","volume":"290","author":"Khalaf","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.ejon.2023.102355_bib21","article-title":"Nurses' comfort care of transarterial chemoembolization patients based on their perceptions around postembolization syndrome and symptom interference","author":"Kim","year":"2022","journal-title":"Nurs Open"},{"issue":"9","key":"10.1016\/j.ejon.2023.102355_bib22","first-page":"7773","article-title":"Impact of discriminant factors on the comfort-care of nurses caring for trans-arterial chemoembolisation patients","volume":"30","author":"Kim","year":"2022","journal-title":"Support. Care Cancer"},{"issue":"1","key":"10.1016\/j.ejon.2023.102355_bib23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/hep.28453","article-title":"Lipiodol transarterial chemoembolization for hepatocellular carcinoma: a systematic review of efficacy and safety data","volume":"64","author":"Lencioni","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.ejon.2023.102355_bib24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.ejon.2023.102355_bib25","article-title":"Treatment response, survival, and safety of transarterial chemoembolization with CalliSpheres((R)) microspheres versus conventional transarterial chemoembolization in hepatocellular carcinoma: a Meta-Analysis","volume":"11","author":"Liang","year":"2021","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.ejon.2023.102355_bib26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.hpb.2017.10.004","article-title":"Surgical resection versus transarterial chemoembolization for BCLC intermediate stage hepatocellular carcinoma: a systematic review and meta-analysis","volume":"20","author":"Liang","year":"2018","journal-title":"HPB (Oxford)"},{"issue":"1","key":"10.1016\/j.ejon.2023.102355_bib27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.20344\/amp.8976","article-title":"Risk factors for the development of postembolization syndrome after transarterial chemoembolization for hepatocellular carcinoma treatment","volume":"31","author":"Lima","year":"2018","journal-title":"Acta Med. Port."},{"key":"10.1016\/j.ejon.2023.102355_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5068228","article-title":"Clinical study on effect of solution focused approach on the complications, pain, sleep, and quality of life in patients with hepatocellular carcinoma undergoing TACE","volume":"2021","author":"Ma","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"issue":"12","key":"10.1016\/j.ejon.2023.102355_bib29","first-page":"7456","article-title":"Comparison of treatment efficacy and safety between drug-eluting bead transarterial chemoembolization with CalliSpheres((R)) microspheres and conventional transarterial chemoembolization as first-line treatment in hepatocellular carcinoma patients","volume":"11","author":"Ma","year":"2019","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"10.1016\/j.ejon.2023.102355_bib30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00270-006-0062-3","article-title":"Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies","volume":"30","author":"Marelli","year":"2007","journal-title":"Cardiovasc. Intervent. Radiol."},{"issue":"2","key":"10.1016\/j.ejon.2023.102355_bib31","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the american association for the study of liver diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.ejon.2023.102355_bib32","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/hpb.12487","article-title":"Post-embolization syndrome as an early predictor of overall survival after transarterial chemoembolization for hepatocellular carcinoma","volume":"17","author":"Mason","year":"2015","journal-title":"HPB (Oxford)"},{"issue":"2","key":"10.1016\/j.ejon.2023.102355_bib33","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/SGA.0b013e318288c8be","article-title":"Improving outcomes for patients receiving transarterial chemoembolization for hepatocellular carcinoma","volume":"36","author":"Mccurdy","year":"2013","journal-title":"Gastroenterol. Nurs."},{"issue":"28","key":"10.1016\/j.ejon.2023.102355_bib34","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.2217\/fon-2018-0136","article-title":"DEB-TACE: a standard review","volume":"14","author":"Melchiorre","year":"2018","journal-title":"Future Oncol."},{"issue":"6","key":"10.1016\/j.ejon.2023.102355_bib35","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jhep.2011.03.024","article-title":"Embolization of hepatocellular carcinoma with drug-eluting beads: doxorubicin tissue concentration and distribution in patient liver explants","volume":"55","author":"Namur","year":"2011","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.ejon.2023.102355_bib36","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jvir.2009.10.026","article-title":"Drug-eluting beads for liver embolization: concentration of doxorubicin in tissue and in beads in a pig model","volume":"21","author":"Namur","year":"2010","journal-title":"J. Vasc. Intervent. Radiol."},{"key":"10.1016\/j.ejon.2023.102355_bib37","first-page":"D4787","article-title":"Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma","volume":"3","author":"Oliveri","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"10.1016\/j.ejon.2023.102355_bib38","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update","volume":"11","author":"Omata","year":"2017","journal-title":"Hepatol. Int."},{"issue":"5","key":"10.1016\/j.ejon.2023.102355_bib39","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.1007\/s00330-020-07404-5","article-title":"Predictive factors of severe abdominal pain during and after transarterial chemoembolization for hepatocellular carcinoma","volume":"31","author":"Pachev","year":"2021","journal-title":"Eur. Radiol."},{"issue":"3","key":"10.1016\/j.ejon.2023.102355_bib40","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jvir.2012.11.023","article-title":"Safety and efficacy of drug-eluting bead chemoembolization for hepatocellular carcinoma: comparison of small-versus medium-size particles","volume":"24","author":"Padia","year":"2013","journal-title":"J. Vasc. Intervent. Radiol."},{"issue":"3","key":"10.1016\/j.ejon.2023.102355_bib41","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3727\/096504019X15766663541105","article-title":"The comprehensive analysis of efficacy and safety of CalliSpheres((R)) Drug-Eluting beads transarterial chemoembolization in 367 liver cancer patients: a Multiple-Center, cohort study","volume":"28","author":"Peng","year":"2020","journal-title":"Oncol. Res."},{"issue":"6","key":"10.1016\/j.ejon.2023.102355_bib42","doi-asserted-by":"crossref","first-page":"W706","DOI":"10.2214\/AJR.13.12308","article-title":"Survival, efficacy, and safety of small versus large doxorubicin drug-eluting beads TACE chemoembolization in patients with unresectable HCC","volume":"203","author":"Prajapati","year":"2014","journal-title":"AJR Am. J. Roentgenol."},{"issue":"23","key":"10.1016\/j.ejon.2023.102355_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14235847","article-title":"Conventional vs. Drug-Eluting beads transarterial chemoembolization for unresectable hepatocellular Carcinoma-A propensity score weighted comparison of efficacy and safety","volume":"14","author":"Savic","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ejon.2023.102355_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.1010824","article-title":"Hepatic arterial infusion chemotherapy versus transarterial chemoembolization for unresectable hepatocellular carcinoma: a systematic review with meta-analysis","volume":"10","author":"Si","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"18","key":"10.1016\/j.ejon.2023.102355_bib45","doi-asserted-by":"crossref","first-page":"808","DOI":"10.4254\/wjh.v9.i18.808","article-title":"Conventional vs drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma","volume":"9","author":"Song","year":"2017","journal-title":"World J. Hepatol."},{"issue":"4","key":"10.1016\/j.ejon.2023.102355_bib46","doi-asserted-by":"crossref","first-page":"389","DOI":"10.5582\/bst.2017.01202","article-title":"The clinical management of hepatocellular carcinoma worldwide: a concise review and comparison of current guidelines from 2001 to 2017","volume":"11","author":"Song","year":"2017","journal-title":"Biosci. Trends"},{"issue":"1","key":"10.1016\/j.ejon.2023.102355_bib47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3727\/096504019X15662966719585","article-title":"Efficacy and safety of Drug-Eluting beads transarterial chemoembolization by CalliSpheres((R)) in 275 hepatocellular carcinoma patients: results from the Chinese CalliSpheres((R)) transarterial chemoembolization in liver cancer (CTILC) study","volume":"28","author":"Sun","year":"2020","journal-title":"Oncol. Res."},{"issue":"3","key":"10.1016\/j.ejon.2023.102355_bib48","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.ejon.2023.102355_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2020.108966","article-title":"Multicentre prospective study of drug-eluting bead chemoembolisation safety using tightly calibrated small microspheres in non-resectable hepatocellular carcinoma","volume":"126","author":"Urbano","year":"2020","journal-title":"Eur. J. Radiol."},{"issue":"2","key":"10.1016\/j.ejon.2023.102355_bib50","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4103\/jcrt.JCRT_504_19","article-title":"A comparison between drug-eluting bead-transarterial chemoembolization and conventional transarterial chemoembolization in patients with hepatocellular carcinoma: a meta-analysis of six randomized controlled trials","volume":"16","author":"Wang","year":"2020","journal-title":"J. Cancer Res. Therapeut."},{"issue":"1","key":"10.1016\/j.ejon.2023.102355_bib51","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5582\/bst.2022.01061","article-title":"The clinical management of hepatocellular carcinoma worldwide: a concise review and comparison of current guidelines: 2022 update","volume":"16","author":"Wen","year":"2022","journal-title":"Biosci. Trends"},{"issue":"8","key":"10.1016\/j.ejon.2023.102355_bib52","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/sj.bjc.6601329","article-title":"Postchemoembolisation syndrome--tumour necrosis or hepatocyte injury?","volume":"89","author":"Wigmore","year":"2003","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.ejon.2023.102355_bib53","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/1534735415617020","article-title":"Jian pi li qi decoction alleviated postembolization syndrome following transcatheter arterial chemoembolization for hepatocellular carcinoma: a randomized, Double-Blind, Placebo-Controlled trial","volume":"15","author":"Xu","year":"2016","journal-title":"Integr. Cancer Ther."},{"issue":"5","key":"10.1016\/j.ejon.2023.102355_bib54","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s12072-018-9888-4","article-title":"Liver resection versus transarterial chemoembolization for the initial treatment of Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma","volume":"12","author":"Yang","year":"2018","journal-title":"Hepatol. Int."},{"issue":"2","key":"10.1016\/j.ejon.2023.102355_bib55","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/acm.2008.0093","article-title":"A new way: alleviating postembolization syndrome following transcatheter arterial chemoembolization","volume":"15","author":"Yinglu","year":"2009","journal-title":"J. Alternative Compl. Med."},{"key":"10.1016\/j.ejon.2023.102355_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.956712","article-title":"Gender disparity and temporal trend of liver cancer in China from 1990 to 2019 and predictions in a 25-year period","volume":"10","author":"Yue","year":"2022","journal-title":"Front. Public Health"},{"issue":"4","key":"10.1016\/j.ejon.2023.102355_bib57","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2214\/AJR.20.24708","article-title":"Imaging changes and clinical complications after Drug-Eluting bead versus conventional transarterial chemoembolization for unresectable hepatocellular carcinoma: multicenter study","volume":"217","author":"Zhang","year":"2021","journal-title":"AJR Am. J. Roentgenol."},{"issue":"35","key":"10.1016\/j.ejon.2023.102355_bib58","article-title":"Effects of high-quality nursing care on psychological outcomes and quality of life in patients with hepatocellular carcinoma: a protocol of systematic review and meta-analysis","volume":"99","author":"Zhang","year":"2020","journal-title":"Medicine (Baltim.)"}],"container-title":["European Journal of Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1462388923000893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1462388923000893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T20:26:55Z","timestamp":1761424015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1462388923000893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":58,"alternative-id":["S1462388923000893"],"URL":"https:\/\/doi.org\/10.1016\/j.ejon.2023.102355","relation":{},"ISSN":["1462-3889"],"issn-type":[{"value":"1462-3889","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and predictors of abdominal pain after transarterial chemoembolization of hepatocellular carcinoma: a single-center retrospective study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejon.2023.102355","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102355"}}